Contact us

ASX Announcements

Here you will find copies of all non-compliance related ASX Announcements made by Bio-Gene (ASX:BGT) since its listing on 29 November 2017.  For a complete list of ASX Announcements go to the ASX website.

11-10-2018 LATEST RESEARCH PROJECT IMPROVES MANUFACTURING PROCESS FOR FLAVOCIDE™
09-10-2018 POSITIVE RESULTS FROM 28-DAY TOXICOLOGY STUDY ON FLAVOCIDE™
12-09-2018 POSITIVE RESULTS FOR FLAVOCIDE™ IN INITIAL FIELD TESTING
05-09-2018 POSITIVE EFFICACY RESULTS FOR FLAVOCIDE™ IN NEW PEST TYPES
23-08-2018 Appendix 4E and Annual Report - 30 June 2018
26-07-2018 Appendix 4C - 30 June 2018
23-07-2018 POSITIVE RESULTS FOR FLAVOCIDE IN SAFETY STUDY FOR BENEFICIAL INSECTS
10-07-2018 BIO-GENE SUBMITS TWO NEW INTERNATIONAL PATENT APPLICATIONS
03-07-2018 QCIDE PERSONAL INSECT REPELLENT FORMULATIONS SHOWN TO BE HIGHLY EFFECTIVE IN FIRST HUMAN EXPOSURE TESTS. EXPANSION OF TREE DEVELOPMENT PROGRAM FOR QCIDE OIL PRODUCTION
26-06-2018 EXPANSION OF FLAVOCIDE MODE OF ACTION STUDIES
18-06-2018 BEE SAFETY STUDY DELIVERS POSITIVE FINDINGS FOR FLAVOCIDE™
28-05-2018 POSITIVE RESULTS WITH FLAVOCIDE™ VS. GRAIN STORAGE PESTS
30-04-2018 APPENDIX 4C - 31 MARCH 2018
26-04-2018 POSITIVE RESULTS IN EFFICACY TEST WITH FLAVOCIDE™ AGAINST ANOTHER MAJOR AGRICULTURAL PEST
17-04-2018 MANUFACTURING DEVELOPMENT PROJECT WITH CSIRO ADVANCES TO STAGE 3
09-04-2018 POSITIVE RESULTS IN EFFICACY TEST FOR FLAVOCIDE™ WITH MAJOR CEREAL CROP PEST
26-03-2018 POSITIVE RESULTS IN EFFICACY TEST FOR FLAVOCIDE™ WITH MAJOR RICE PEST
21-03-2018 ANIMAL HEALTH TESTING AND COLLABORATION UPDATE
01-03-2018 Prospectus for Loyalty Options Lodged
01-03-2018 Prospectus for Loyalty Options
20-02-2018 Loyalty Options Update
14-02-2018 KEY APPOINTMENTS TO ADVISORY & MANAGEMENT TEAMS
08-02-2018 Appendix 4D - Half Year Report - 31 December 2017
31-01-2018 PILOT STUDY SHOWS FLAVOCIDE™ ACTIVITY AGAINST SUSCEPTIBLE AND RESISTANT MOSQUITOS
30-01-2018 Appendix 4C - December 2017
21-12-2017 BIO-GENE – 2018 GOALS AND OBJECTIVES FOLLOWING SUCCESSFUL IPO
19-12-2017 BIO-GENE ANNOUNCES POSITIVE SAFETY RESULTS
11-12-2017 BIO-GENE REPORTS POSITIVE INITIAL EFFICACY RESULTS
04-12-2017 BIO-GENE APPOINTS MR DOUG RATHBONE AS AN ADVISOR
01-12-2017 BIO-GENE EXTENDS RESEARCH COLLABORATION WITH QDAF
30-11-2017 BIO-GENE EXTENDS RESEARCH COLLABORATION WITH CSIRO
29-11-2017 BIO-GENE COMPLETES $7.1M IPO TO LIST ON ASX